Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach Enrico FabrisAbi SelvarajahArnoud van’t Hof Review Article Open access 22 March 2022 Pages: 463 - 474
Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies Jordan L. LacosteThomas W. SzymanskiArshad Jahangir Review Article 30 March 2022 Pages: 475 - 496
The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review Jay M. EdelbergAmy J. SehnertRobert McDowell Review Article Open access 18 April 2022 Pages: 497 - 510
Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis Boon-Hao SuahZhi-Yan LeeChing-Hui Sia Systematic Review 16 March 2022 Pages: 511 - 521
The Effect of Vasopressin and Methylprednisolone on Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis of Randomized Controlled Trials Basel AbdelazeemAhmed K. AwadArvind Kunadi Systematic Review 22 March 2022 Pages: 523 - 533
Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study Mohammad AbumayyalehJonathan DemmerIbrahim Akin Original Research Article Open access 30 March 2022 Pages: 535 - 544
Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis Nihar R. DesaiCaresse CampbellJoaquim Cristino Original Research Article Open access 21 May 2022 Pages: 545 - 556
Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study Langjing HuangZhihua YuXiaoke Shang Original Research Article 18 June 2022 Pages: 557 - 565
Contemporary Trends in the Use of and Expenditures on Digoxin in the United States Abdullah A. AlahmedJulie C. LauffenburgerLeo F. Buckley Original Research Article 24 June 2022 Pages: 567 - 575
Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction Rungroj KrittayaphongUnchalee Permsuwan Original Research Article 07 July 2022 Pages: 577 - 590